- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05936307
Externalization and Stimulation (STUPEFIX)
Modulation of Auditory Externalization Abilities by Transcranial Stimulation of the Brain Area Specifically Involved
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marine MONDINO, PhD
- Phone Number: +33 0437915565
- Email: marine.mondino@ch-le-vinatier.fr
Study Contact Backup
- Name: Lydie SARTELET
- Phone Number: +33 0437915531
- Email: lydie.sartelet@ch-le-vinatier.fr
Study Locations
-
-
-
Bron, France, 69678
- Recruiting
- Centre Hospitalier le Vinatier
-
Contact:
- Marine Mondino
- Phone Number: +33 0437915565
- Email: marine.mondino@ch-le-vinatier.fr
-
Contact:
- Jérôme Brunelin
- Phone Number: +33 0437915297
- Email: jerome.brunelin@ch-le-vinatier.fr
-
Sub-Investigator:
- Jerome Brunelin
-
Principal Investigator:
- Marine Mondino
-
Sub-Investigator:
- Frédéric Haesebaert
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having given their written informed consent
- Affiliated with a social security scheme
- French speakers and readers
Exclusion Criteria:
- With contraindication to HD-tDCS stimulation or fMRI
- With a history of or current hearing problems, including tinnitus
- Taking medication (except contraceptives)
- With a history of or current psychiatric diagnosis (DSM-5 criteria)
- First-degree relatives with a diagnosis of schizophrenia spectrum disorder or bipolar disorder (DSM5)
- Have a personal history of neurological disorders or head trauma with loss of consciousness
- With an intellectual disability (Raven's Matrices)
- With developed musical abilities (i.e., regular practice of a musical instrument for at least 10 years with assiduity or at a music school or conservatory)
- Pregnant or nursing
- Being in a period of exclusion and/or having exceeded the annual indemnity ceiling (€4,500) for other clinical research.
- Under guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 15 healthy participants active then placebo
15 healthy participants will receive a session of active HD-tDCS and then a session of placebo HD-tDCS.
|
Participants will receive a session of active HD-tDCS at a current intensity of 2 mA for a duration of 25min.
The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI.
During the stimulation, participants will be engaged in a computer-based externalization task.
Participants will receive a session of placebo HD-tDCS, which will be delivered following the same procedures as active HD-tDCS but the intensity of the current will be set at 2mA during the 30 first seconds at the beginning of the 25-min period of the stimulation, and equal to 0 mA for the reminding period of stimulation to simulate the tingling sensation often experienced by individuals during active stimulation. The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI. During the stimulation, participants will be engaged in a computer-based externalization task |
|
Placebo Comparator: 15 healthy participants placebo then active
15 healthy participants will receive a session of placebo HD-tDCS and then a session of active HD-tDCS.
|
Participants will receive a session of active HD-tDCS at a current intensity of 2 mA for a duration of 25min.
The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI.
During the stimulation, participants will be engaged in a computer-based externalization task.
Participants will receive a session of placebo HD-tDCS, which will be delivered following the same procedures as active HD-tDCS but the intensity of the current will be set at 2mA during the 30 first seconds at the beginning of the 25-min period of the stimulation, and equal to 0 mA for the reminding period of stimulation to simulate the tingling sensation often experienced by individuals during active stimulation. The placement of electrodes will be determined to specifically target the brain area that has been identified as being involved in the process of externalization, as evidenced by fMRI. During the stimulation, participants will be engaged in a computer-based externalization task |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Externalization abilities
Time Frame: one year
|
proportion of sounds perceived as coming from an external source in the externalization task (range 0-100%)
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reality monitoring performance
Time Frame: one year
|
Scores obtained at the reality monitoring task (Brunelin et al., 2006) (accuracy, range = 0-100%)
|
one year
|
|
Self-agency
Time Frame: one year
|
Percentage of voice deviation in the self-agency task (Subramaniam et al., 2018) (pitch perturbation and variability in peak deviation in cents, cents(t) = 1200 log2 (Hertz(t )/HertzRef), mean pitch perturbation response tracks = ±100 and ± 400)
|
one year
|
|
Psychometric characteristics that may influence externalization abilities and stimulation effects
Time Frame: baseline
|
Launay-Slade Hallucinations Scale scores between 0 and 64 (LSHS; Launay and Slade)
|
baseline
|
|
Psychometric characteristics that may influence externalization abilities and stimulation effects
Time Frame: baseline
|
Plymouth Sensory Imagery Questionnaire (PSIQ).Scores between 0 and 70.
|
baseline
|
|
Side effects of stimulation
Time Frame: 1 time before (baseline) and within 1 hour after stimulation
|
Scores at the questionnaire on side effects of stimulation.
Scores between 10 and 44 (higher scores mean worse outcome)
|
1 time before (baseline) and within 1 hour after stimulation
|
|
Mood
Time Frame: 1 time before (baseline) and within 1 hour after stimulation
|
Mood self-questionnaire.
Scores between 0 and 100 (higher scores mean worse outcome)
|
1 time before (baseline) and within 1 hour after stimulation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marine MONDINO, Phd, hospital le vinatier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2023-A00452-43
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Participants
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Not yet recruitingHealthy Participants | Healthy Adult ParticipantsUnited States
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Touro University, CaliforniaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingHealthy Participants | Obese But Otherwise Healthy ParticipantsUnited States
-
Beijing Tide Pharmaceutical Co., LtdRecruitingHealthy | Healthy ParticipantsChina
-
Aston UniversityCooperVision, Inc.Enrolling by invitationHealthy | Healthy ParticipantsUnited Kingdom
-
Universidad San SebastiánAgencia Nacional de Investigación y DesarrolloNot yet recruitingHealthy | Healthy Adult ParticipantsChile
-
Standard Process Inc.Recruiting
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
Simcere Pharmaceutical Co., LtdNot yet recruiting
-
Fresenius KabiOxford Brookes UniversityNot yet recruiting
Clinical Trials on High-definition transcranial direct current (HD-tDCS), active condition
-
Hôpital le VinatierNot yet recruiting
-
University of New MexicoUniversity of Miami; The City College of New York; The Mind Research Network; New... and other collaboratorsCompletedMild Traumatic Brain InjuryUnited States
-
Monash UniversityZonMw: The Netherlands Organisation for Health Research and Development; Erasmus...Completed
-
University of Sao PauloThomas Jefferson University; The São Paulo Research Foundation (FAPESP); Vias... and other collaboratorsRecruiting
-
University of TehranRecruitingHealthy VolunteersIran, Islamic Republic of
-
University of Bernki:elementsRecruitingAging | Healthy Volunteer | Depressive Disorder, Major Depressive DisorderSwitzerland
-
Anhui Medical UniversityRecruitingTranscranial Direct Current Stimulation | Non Suicidal Self InjuryChina
-
WANG KAICompletedHealthy Adults | Transcranial Direct Current StimulationChina
-
Kessler FoundationCompletedTraumatic Brain Injury | Upper Extremity DysfunctionUnited States